×

Valeant buys Sprout in $1 billion cash deal

7:32 AM ET Thu, 20 Aug 2015

Michael Pearson, Valeant Pharma chairman & CEO, and Cindy Whitehead, Sprout Pharma CEO, discuss Valeant's acquisition of Sprout and its new female libido drug Addyi. With CNBC's Meg Tirrell.